EULAR Revenue and Competitors

Kilchberg,

Location

N/A

Total Funding

Estimated Revenue & Valuation

  • EULAR's estimated annual revenue is currently $15.7M per year.(i)
  • EULAR's estimated revenue per employee is $140,000

Employee Data

  • EULAR has 112 Employees.(i)
  • EULAR grew their employee count by 27% last year.

EULAR's People

NameTitleEmail/Phone
1
Head Operations (COO)Reveal Email/Phone
2
Chair-elect Advocacy CommitteeReveal Email/Phone
3
Scientific Programme CoordinatorReveal Email/Phone
4
EULAR PARE Committee ChairReveal Email/Phone
5
Event CoordinatorReveal Email/Phone
6
Event AssistantReveal Email/Phone
7
Project CoordinatorReveal Email/Phone
8
Education Coordinator | Digital LearningReveal Email/Phone
9
EULAR Past PresidentReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$223.4M11165%$65MN/A
#2
$13.6M972%$23.1MN/A
#3
$1.1M13N/AN/AN/A
#4
$87.5M492-4%$206MN/A
#5
$41.9M27218%N/AN/A
#6
$53.4M30522%N/AN/A
#7
$55.8M314-5%$102.6MN/A
#8
$13.6M9713%N/AN/A
#9
$0.2M3N/AN/AN/A
#10
$2.8M29N/AN/AN/A
Add Company

What Is EULAR?

The European Alliance of Associations for Rheumatology, EULAR, is the organisation which represents the people with arthritis/rheumatism, health professionals in rheumatology (HPR) and scientific societies of rheumatology of all the European nations. EULAR aims to reduce the impact of rheumatic and musculoskeletal diseases (RMDs) on the individual and society and to improve the social position and the quality of life of people with rheumatic and musculoskeletal diseases in Europe. To this end, EULAR stimulates, promotes and supports education, research, prevention and treatment of rheumatic and musculoskeletal diseases. These include the diseases of the musculoskeletal or locomotor system as well as systemic immune mediated diseases.

keywords:N/A

N/A

Total Funding

112

Number of Employees

$15.7M

Revenue (est)

27%

Employee Growth %

N/A

Valuation

N/A

Accelerator

EULAR News

2022-04-19 - EULAR/ACR: Complex immunodysregulatory diseases ...

... require a multidisciplinary approach, according to joint guidelines released by EULAR and the American College of Rheumatology.

2022-04-19 - EULAR/ACR Releases Points-to-Consider for Management of ...

EULAR/ACR Releases Points-to-Consider for Management of Autoinflammatory Type I Interferonopathies (CANDLE/PRAAS, SAVI, and AGS). Dhivya...

2022-04-17 - 2021 EULAR Recommendations on Lifestyle Behaviors and ...

The full report was published in Annals of the Rheumatic Diseases. The recommendations were developed by a EULAR taskforce using an evidence-...